Clinical Trial Update: Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial assesses the safety and efficacy of 12 weeks of varenicline for smoking cessation in smokers with depression; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation, Depression | Phase 4 | Status: COMPLETED | Results posted: 2013-04-16